Medicis Pharmaceutical Corp. (MRX) Tops Q1 EPS by 10c
Tweet
Share
E-mailGet Alerts MRX Hot Sheet
Price: $72.24 -0.56%
EPS Growth %: +27.1%
Financial Fact:
Loss from discontinued operations, net of income tax benefit: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
EPS Growth %: +27.1%
Financial Fact:
Loss from discontinued operations, net of income tax benefit: 0
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Medicis Pharmaceutical Corp. (NASDAQ: MRX) reported Q1 EPS of $1.48, $0.10 better than the analyst estimate of $1.38. Revenue for the quarter came in at $692.3 million versus the consensus estimate of $686.37 million.
For earnings history and earnings-related data on Medicis Pharmaceutical Corp. (MRX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Paramount Weighs Tapping Musk For Equity Investment - Semafor
- Scotiabank Reiterates Sector Outperform Rating on Hemlo Mining (HMMC:CN)
- Paychex (PAYX) Tops Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
